NC
RGEN icon

Northpointe Capital’s Repligen RGEN Stock Holding History

Northpointe Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-76,718
Closed -$2.33M – 230
2015
Q1 		$2.33M Sell
76,718
-130,719
-63% -$3.39M 0.25% 135
2014
Q4 		$4.11M Sell
207,437
-152,975
-42% -$3.42M 0.49% 65
2014
Q3 		$7.18M Buy
360,412
+35,760
+11% +$753K 0.76% 50
2014
Q2 		$7.4M Sell
324,652
-596,920
-65% -$10.6M 0.71% 56
2014
Q1 		$11.9M Sell
921,572
-638,748
-41% -$9.16M 1.2% 25
2013
Q4 		$21.3M Sell
1,560,320
-254,209
-14% -$3.03M 1.88% 3
2013
Q3 		$20.1M Sell
1,814,529
-404,048
-18% -$4.02M 2.36% 1
2013
Q2 		$18.3M Buy
+2,218,577
New +$18.6M 2.11% 6

Other funds holding RGEN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northpointe Capital's RGEN Position: Q2 2015 in Review

Northpointe Capital sold out of Repligen (RGEN) in Q2 2015, closing a stake of 76,718 shares — an estimated $2.33M sold.

Northpointe Capital first reported a position in RGEN in Q2 2013 and held it in 8 quarters. The position peaked at $21.3M in Q4 2013. 174 funds tracked by Wall St. Rank hold RGEN as of Q2 2015.

  • Northpointe Capital reported no remaining Repligen position as of Q2 2015 after selling out during the quarter.
  • Northpointe Capital sold 76,718 Repligen shares in Q2 2015, an estimated $2.33M.
  • Northpointe Capital first reported a position in Repligen in Q2 2013 and held it in 8 quarters.
  • Northpointe Capital's Repligen position peaked at $21.3M in Q4 2013.
  • 174 funds tracked by Wall St. Rank held Repligen as of Q2 2015.

Based on Northpointe Capital's 13F filing for Q2 2015, filed 30 Jul 2015.